Loading stock data...

Symbiox Investment & Trading Co Ltd

BSE: SYMBIOX

BSE
3.00 0.00 (0.00%)

Prev Close

3

Open Price

3

Volume

12,691

Today Low / High

2.9 / 3

52 WK Low / High

2.15 / 6.02

Range

3 - 3

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 3, reflecting a change of 0 (0%). The expected target range on the BSE is 3 - 3. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

19 Nov 3.00 0.00%
18 Nov 3.00 0.00%
17 Nov 2.95 1.69%
14 Nov 2.95 0.00%
13 Nov 3.00 0.00%
12 Nov 3.00 0.00%
11 Nov 3.00 1.67%
10 Nov 2.99 -2.68%
07 Nov 2.94 3.74%
06 Nov 3.10 -5.48%
04 Nov 2.91 4.81%
03 Nov 2.98 -2.35%
31 Oct 2.81 6.05%
30 Oct 2.92 0.00%
29 Oct 3.01 -3.32%
28 Oct 3.15 -4.13%
27 Oct 3.59 -13.37%
24 Oct 3.70 -2.97%
23 Oct 2.85 8.42%

Symbiox Investment & Trading Co Ltd Graph

Symbiox Investment & Trading Co Ltd Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Symbiox Investment & Trading Co Ltd T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 3.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 3.00 3.03 2.73 - 3.33
3.06 2.45 - 3.67
3.09 2.16 - 4.02
Bearish Scenario 3.00 2.97 2.67 - 3.27
2.94 2.35 - 3.53
2.91 2.04 - 3.78

Overview of Symbiox Investment & Trading Co Ltd

ISIN

INE653R01012

Industry

Investment - Banking & Investment Services

Vol.Avg

43,139

Market Cap

93,861,990

Last Dividend

0

Official Website

Visit Website

IPO Date

2015-12-10

DCF Diff

4.63

DCF

-2

Financial Ratios Every Investor Needs

Stock Rating Details for SYMBIOX

Metric Value Recommendation
Overall Rating C Sell
DCF Score 1 Strong Sell
ROE Score 2 Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 4 Buy

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 2.76 Cr 2.11 Cr 0.65 Cr 0.2349 0.00 Cr 0.01 Cr 0.26 Cr 0.19 Cr 0.06 0.26 Cr 0.0694
2024-03-31 3.90 Cr 3.47 Cr 0.42 Cr 0.1087 0.00 Cr 0.05 Cr 0.20 Cr 0.21 Cr 0.07 0.25 Cr 0.0534
2023-03-31 3.98 Cr 3.23 Cr 0.75 Cr 0.1885 0.00 Cr 0.05 Cr 0.30 Cr 0.16 Cr 0.05 0.22 Cr 0.0400
2022-03-31 1.83 Cr 1.09 Cr 0.74 Cr 0.4018 0.00 Cr 0.05 Cr 0.21 Cr 0.14 Cr 0.04 0.19 Cr 0.0759
2021-03-31 2.08 Cr 2.53 Cr -0.45 Cr -0.2185 0.00 Cr 0.02 Cr -0.91 Cr 0.07 Cr 0.02 0.09 Cr 0.0334

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.23 Cr 31.97 Cr 0.24 Cr 31.7239 Cr 0.00 Cr -0.23 Cr 1.30 Cr 0.02 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.2420 Cr
2024-03-31 0.31 Cr 31.84 Cr 0.30 Cr 31.5321 Cr 0.00 Cr -0.31 Cr 0.09 Cr 0.02 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.3045 Cr
2023-03-31 0.54 Cr 32.76 Cr 1.44 Cr 31.3238 Cr 0.00 Cr -0.54 Cr 0.21 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 1.4387 Cr
2022-03-31 0.19 Cr 31.81 Cr 0.65 Cr 31.1669 Cr 0.00 Cr -0.19 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.6470 Cr
2021-03-31 0.15 Cr 33.25 Cr 2.29 Cr 30.9623 Cr 0.00 Cr -0.15 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 2.2893 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 3.5736 Cr -2.8358 Cr 0.0000 Cr 3.5736 Cr 0.7469 Cr 1.0588 Cr 0.0000 Cr 0.1919 Cr 0.0000 Cr 0.0000 Cr -1.2068 Cr
2024-03-31 -3.0596 Cr 2.8295 Cr 0.0000 Cr -3.0739 Cr -0.2301 Cr 0.3119 Cr -0.0143 Cr 0.2475 Cr 0.0000 Cr 0.0000 Cr 0.1184 Cr
2023-03-31 -4.4725 Cr 4.8222 Cr 0.0000 Cr -4.4725 Cr 0.3497 Cr 0.5421 Cr 0.0000 Cr 0.2155 Cr 0.0000 Cr 0.0000 Cr -0.2080 Cr
2022-03-31 -0.3510 Cr 0.3954 Cr 0.0000 Cr -0.3510 Cr 0.0444 Cr 0.1923 Cr 0.0000 Cr 0.1877 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr
2021-03-31 1.1359 Cr -0.9969 Cr 0.0000 Cr 1.1359 Cr 0.1390 Cr 0.1479 Cr 0.0000 Cr 0.0938 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 0.46 Cr 0.23 Cr 0.23 Cr 0.4918 0.09 Cr 0.07 Cr 0.02 0.09 Cr 0.1460
2025-03-31 1.25 Cr 1.57 Cr -0.32 Cr -0.2575 -0.41 Cr -0.30 Cr -0.10 -0.41 Cr -0.2405
2024-12-31 0.45 Cr 0.19 Cr 0.27 Cr 0.5870 0.21 Cr 0.16 Cr 0.05 0.22 Cr 0.3486
2024-09-30 0.75 Cr 0.24 Cr 0.52 Cr 0.6857 0.30 Cr 0.33 Cr 0.11 0.44 Cr 0.4353
2024-06-30 0.31 Cr 0.12 Cr 0.19 Cr 0.6004 0.15 Cr 0.01 Cr 0.00 0.01 Cr 0.0179

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-06-30 0.00 Cr 0.00 Cr 13.77 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -31.72 Cr
2025-03-31 0.23 Cr 13.82 Cr 14.04 Cr 16.61 Cr 1.30 Cr 31.95 Cr 0.02 Cr 31.97 Cr 0.24 Cr
2024-12-31 0.00 Cr 0.00 Cr 11.12 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -31.86 Cr
2024-09-30 0.11 Cr 11.22 Cr 11.34 Cr 0.55 Cr 0.51 Cr 32.01 Cr 0.02 Cr 32.03 Cr 0.16 Cr
2024-06-30 10.20 Cr 0.00 Cr 10.20 Cr 0.00 Cr 0.00 Cr 10.20 Cr 0.00 Cr 0.00 Cr -31.53 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 0.07 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 -0.30 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 0.16 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 0.33 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.01 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Investment - Banking & Investment Services

No stocks found in this industry.

Key Executives

MD & Whole Time Executive Director
Mr. Samit Ray

Gender: male

Year Born: 1965

Chief Financial Officer & Executive Director
Ms. Sunita Show

Gender: female

Year Born: 1986

Company Secretary & Compliance Officer
Ms. Khushboo Pitti

Gender: female

Year Born: 1987

FAQs about Symbiox Investment & Trading Co Ltd

Who is the CEO of the company?

The CEO is Samit Ray.

What is the current market price of the stock?

The current price is ₹3.00.

What is the 52-week price range?

The range is ₹2.15-6.02.

What is the market capitalization of the company?

The market capitalization is ₹9.39 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 37.75.

Which sector does the company belong to?

The company operates in the Financial Services sector.

What does the company do?

Overview of Symbiox Investment & Trading Co Ltd (ISIN: INE653R01012) is a leading Investment - Banking & Investment Services in India. With a market capitalization of ₹9.39 crores and an average daily volume of 43,139 shares, it operates in the Investment - Banking & Investment Services. The company last declared a dividend of ₹0.